Skip to content

Intensive Versus Traditional Voice Therapy

Voice-related Outcomes in Response to Intensive Versus Traditional Therapy Programs

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03129880
Enrollment
15
Registered
2017-04-26
Start date
2016-03-13
Completion date
2024-03-12
Last updated
2024-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysphonia

Keywords

Voice disorder, Hoarseness, Phonation Disorders, Speech Disorders

Brief summary

The purpose of this study is to determine if there are differences in treatment outcomes between traditional voice therapy, performed weekly for a maximum of 6 weeks versus intensive voice therapy, consisting of 4-6 therapy sessions performed within one day.

Detailed description

The goal of voice therapy is optimal long-term vocal quality and communication function with minimal recurrence. Traditional voice therapy for dysphonia typically consists of one to two therapy sessions each week with a single clinician for about 8 weeks. Another approach of voice therapy is intensive short-term therapy also known as boot camp. This approach, borrows from the disciplines of neurobiology, exercise physiology, motor learning, and psychotherapy which describe desirable learning and behavior changes influenced by practice that involves high-intensity overload, variability, and specificity of training. A few studies have showed that Boot Camp model of intensive therapy resulted in comparable gains in voice quality and vibratory mechanics and may promote better patient satisfaction and attendance. While such findings support the notion that intensive voice therapy may enhance voice therapy outcomes, no study to date has examined patient response to the Boot Camp approach to voice therapy. The investigators will compare the outcomes of traditional, weekly voice therapy and intensive voice therapy with multiple sessions in one day.

Interventions

BEHAVIORALWeekly Voice Therapy

Participants will be randomized to receive weekly voice therapy

BEHAVIORALIntensive Voice Therapy

Participants will be randomized to receive multiple sessions of voice therapy in one day.

Sponsors

University of Wisconsin, Madison
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

For purposes of this study participants will be randomized into one of the following two groups: 4-6 weekly standard of care therapy sessions, once a week, for a maximum of six weeks 4-6 standard of care therapy sessions in one day Standard of care treatment may continue past patient enrollment in this study.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosed with a Voice disorder * Diagnosed with benign vocal fold lesions and/or hyper-function * First/primary propose treatment modality is voice therapy * Patients who are appropriate for either standard of care treatment modality (traditional or intensive voice therapy) * Willingness to participate in either standard of care treatment modality * All races * Males and females * English speaking

Exclusion criteria

* Younger than 18 * Inability or unwillingness to participate in one of the standard of care treatment modalities * Laryngeal Surgery or procedures during course of study * Prisoners

Design outcomes

Primary

MeasureTime frameDescription
Self-efficacy and readiness scale ChangesBaseline compared to Immediately post voice therapyPre to Post difference in participant's self-efficacy for voice practice and healthy voice technique between therapy groups and within subsets of subjects - readiness ruler of 0 (not at all) to 10 (extremely)
Self-efficacy and readiness scale ChangeBaseline compared to 12 weeks post voice therapyPre to Post difference in participant's self-efficacy for voice practice and healthy voice technique between therapy groups and within subsets of subjects - readiness ruler of 0 (not at all) to 10 (extremely)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026